MedTrace Logo

Conditioned Open Label Placebo for Postoperative Pain Management

NCT06107595 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2024-02-28

No results posted yet for this study

Summary

The primary objective is to evaluate the efficacy of two Conditioned Open Label Placebos (COLP): COLP pill and COLP odor to reduce opioid intake for postoperative (thoracic and spinal surgery) pain management compared to the opioid only usual treatment (TAU).

Conditions

  • Pain, Postoperative

Interventions

BEHAVIORAL

Placebo

Participant take 1 dose placebo (odor or pill) on post-op day 0 (POD 0) and 3 placebo dose from POD 2 to POD 17

Sponsors & Collaborators

  • Centre de Médecine Intégrative et Complémentaire (CEMIC)

    lead OTHER

Principal Investigators

  • Chantal Berna Renella, Prof · Centre de Médecine Intégrative et Complémentaire, Lausanne University hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06107595 on ClinicalTrials.gov